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Background: Previous studies on oxidative state after partial hepatectomy (PHx) report conﬂicting data
on levels of glutathione (GSH) and are mainly presented in rodent models by methodology less sensitive
than the present technologies. The current swine model presents GSH levels and the following genetic
response post-PHx, utilizing an analytical platform more sensitive and precise than earlier available.
Method: Twelve pigs were randomized to a PHx- and a control group (n¼6 in each). The PHx group had
a 60% hepatectomy. Serial in vivo liver biopsies during 12 h of anaesthesia post-PHx were analyzed for
GSH by liquid chromatography mass spectrometry (LC-MS/MS). Transcriptional alterations of genes (GS,
GCLM, GCLC, GR, HGF, NFE2L2, TGFβ1) regulating GSH synthesis were measured by real-time PCR.
Results: No difference was detected between the GSH levels in the PHx- and the control group during the
experiment (P¼0.247). Still, decreased gene expression of GS (P¼0.026) and NFE2L2 (P¼0.014) the ﬁrst
nine hours, and a decrease of TGFβ1 (P¼0.029) the ﬁrst seven hours post-PHx was seen in the liver
remnant.
Conclusion: The results show that the liver has an extended capacity to maintain GSH homeostasis
during major stress and parenchymal loss, even at the early onset of such trauma. This observation was
not explained by increased expression of key genes in GSH pathways. Consequently, the results indicate
an inherent compensatory capacity to maintain GSH homeostasis in the reduced organ.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Glutathione (γ-glutamylcysteinylglycine; GSH) is present as an
ubiquitous compound in virtually all mammalian tissues, parti-
cularly in the liver [15,17]. GSH plays a major role in the defence
against oxidative stress by protecting cells from fatal damage of
reactive oxygen species (ROS). GSH has emerged as the determi-
nant of oxidative state in mammalian cells [19] and is regarded as
a critical intracellular antioxidant [13]. There is growing awareness
that GSH has a protective role by scavenging oxidative stress in
clinical conditions such as malignant diseases, diabetes, athero-
sclerosis, chronic inﬂammation, viral infection, ischemia-B.V. This is an open access article u
s, gene names are typed in
Research, Institute of Clinical
y.
rholmen-Kjær).reperfusion injury in the heart and liver disease [3–
5,7,8,24,25,29,30].
The hepatic GSH homeostasis plays a central role in the defence
against oxidative stress [18,19]. Under physiological conditions,
the liver is protected from oxidative stress by the capacity of he-
patocytes to synthesize GSH [9]. Pathophysiological consequences
of hepatic oxidative damage include dysregulation of lipid meta-
bolism (steatosis), impaired liver function (hepatocyte degenera-
tion and death) and activation of the immune response (in-
ﬂammation and ﬁbrosis/cirrhosis) [22]. Alteration in liver GSH
homeostasis may become manifest in liver diseases such as non-
alcoholic fatty liver disease [23], alcoholic liver disease [1] and
drug-induced liver injury [21]. Yet, the precise mechanism by
which depletion of GSH promotes pathophysiological changes in
the liver has not been clearly deﬁned.
Previous studies have shown that partial hepatectomy (PHx)
inﬂuences the oxidative state in normal and pathologic liver by
increased GSH synthesis after PHx [2]. These studies report ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Experimental setup. Experimental setup The experimental setup including time-points for each analysis. Time-points in hours after laparotomy. GSH ●¼ liver biopsies
for determining glutathione (GSH) values in LC-MS/MS. qPCR ●¼ liver biopsies for gene expression analysis. Before baseline both groups established the anaesthesia
protocol. At baseline both group had a laparotomy before the ﬁrst liver biopsy was collected. Then only the PHx had a 60% liver resection. Both groups were observed 12 h
after baseline with biopsies included.
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nant [7,14,16,28]. Further, the studies are based on less sensitive
analytical platforms and the majority has focused on rodent
models. In contrast, the capacity of the liver to maintain GSH
homeostasis after PHx in large animal models, like swine, has
received little attention despite the fact that porcine liver is more
anatomically and physiologically comparable with human liver.
We recently presented a newly established method of quanti-
fying GSH in swine hepatocytes using liquid chromatography
tandem mass spectrometry (LC-MS/MS), including reference levels
of GSH in swine hepatocytes as supplement to the methodological
approach in future liver GSH research [11]. Moreover, application
of LC-MS/MS in quantifying GSH is limited, and as far as we know,
not yet established as a quantitative method of GSH analysis after
PHx in a porcine model. Additionally, characterizing the gene ex-
pression of GSH related enzymes using speciﬁcally designed reverse
transcription quantitative real-time polymerase chain reaction
(RT-qPCR), has not previously been presented in a swine model.
Accordingly, the primary aim of this study was to investigate
whether a PHx in a swine model would alter the GSH levels in the
liver remnant, using the precision and sensitivity of LC-MS/MS
technique. The second aim was to elucidate possible consequences
in the regulation of key genes in GSH metabolism using RT-qPCR.2. Method
2.1. Animal welfare and preparation
The protocols were approved by the committee of the Norwegian
Experimental Animal Board, and all experiments were conducted in
compliance with the institutional animal care guidelines and the
National Institute of Health's Guide for the Care and Use of La-
boratory Animals [DHHS Publication No. (NIH) 85-23, revised 1985].
A total of 12 female 3 months old Yorkshire/Landrace hybrid pigs,
average weight of 38.2 kg, were stalled and acclimatized in the an-
imal research facilities one week before experiments. A standardized
diet, light-dark cycle and water access was maintained. All animals
fasted overnight with free access to water before experiments were
started between 7 and 8 a.m. One pig had gastroenteritis the days
before surgery, but was included in the experiment.
2.2. Anaesthesia and monitoring
Intramuscular ketamine 15 mg/kg (Narcetan; Véloquinol, Itti-
gen, Switzerland), 1 mg of atropine (Atropin; Nycomed Pharma,
Asker, Norway) and midazolam 1 mg/kg (Midazolam B. Braun,
Melsungen, Germany) were used as premedication before the
animal was cleaned and weighed. Mask inhalation of 4% isoﬂuran
(Isoﬂuran Baxter;Baxter, Irvine, CA) in 100% O2 was given beforeintubation. Gas anaesthesia throughout the experiment was
maintained with isoﬂurane and an alveolar concentration of 0.8–
1.2% mixed with 45–65% oxygen. Deep anaesthesia was induced by
an IV bolus of 0.1 mg/kg fentanyl (50 mg/ml Fentanyl-Hameln:
Hameln Pharmaceuticals Gmbh, Hameln, Germany) and main-
tained with IV infusion of 0.02 mg/kg/h fentanyl and 0.3 mg/kg/h
midazolam. Respiratory rate was adjusted to achieve an Et CO2
between 3.5 and 6 KPa, monitored by a Capnomac Ultima (Datex,
Helsinki, Finland). Mean arterial pressure and heart rate was
monitored through a 20-gauge arterial catheter (BD Arterial Can-
nula with FloSwitch; Ohmeda, Swindon, UK) placed in the super-
ﬁcial femoral artery. Body temperature was maintained at 38.5 °C
by a heating blanket. The urine production was monitored by a
cystotomy and a 20 Ch Foley catheter.
2.3. Infusions
An 18-gauge IV catheter (Optiva 2 18 G; Medex Medical, Ha-
slingden, UK) was placed in the ear vein for infusion of 0.9% so-
dium chloride (B. Braun), fentanyl and midazolam. A 1000 ml in-
itial IV of 0.9% sodium chloride was given during the ﬁrst 45 min
of anaesthesia. The infusion was continued at 20 ml/kg/h for the
rest of the anaesthesia, supplemented by 25 ml glucose (Glucose
50 mg/ml, Fresenius Kabi, Halden, Norway).
2.4. Experimental set up
Twelve pigs were randomized into the PHx group and the control
group by drawing lots (n¼6 for each, see Fig. 1). The experimental
setup consisted of an initial phase in both groups with establish-
ment of the anaesthesia protocol, placement of all catheters and
infusions as described above. The liver surgery was performed in the
PHx group as described under operative procedure. In the control
group only a laparotomy was performed. Both groups were observed
12 h after the partial hepatectomy (PHx group) and the laparotomy
(control group) including serial liver biopsies as described in Fig. 1.
Finally, all animals were sacriﬁced after 12 h by an overdose of IV
Pentobarbital (Ås Produksjonslab AS, Ås, Norway).
2.5. Operative procedure
A midline laparotomy was established in the control group. In
the PHx group a major liver resection was performed. The hepatic
artery supplying segments II and III (left lateral lobe) together with
the portal branch of these segments were located, isolated and
ligated using an absorbable polyﬁlament suture on a large needle.
The parenchyma of segment II and III was crushed by ﬁnger
fracture technique (Lin TY 1958) under inﬂow occlusion to isolate
vessels and bile ducts for ligation. A 0.5-cm wide cotton ribbon
around the base of segments II and III was used after digital
Å. Florholmen-Kjær et al. / Redox Biology 9 (2016) 15–21 17compression to keep occlusion during the resection. The segments
were removed with blood loss between 5–15 ml. The segments
were weighed. Segments IV, V, and VIII (right lateral lobe) were
removed in a similar manner leaving segments VI, VII, and I in
place as a liver remnant. The procedure represented a total liver
resection of approximately 60%, hence a liver remnant in the PHx
group corresponding to approximately 40%. The partial hepa-
tectomy was completed after approximately 30 min.
2.6. Sampling and preparation of liver biopsies
The liver biopsies were collected as presented in Fig. 1 using a
14-gauge biopsy needle (GTA Medical Devices). Biopsies for GSH
analysis by LC-MS/MS and for the qPCR analysis were taken from
the liver remnant in the PHx group and from the liver in the
control group. The sample processing before the LC-MS/MS ana-
lysis started immediately as reported earlier [11]. The biopsies for
the qPCR analysis were immersed directly in RNAlater (Ambion
Inc) and frozen at 70 °C before the RNA isolation took place. The
RNA isolation was performed by using the DNA/RNA Miniprep Kit
from Qiagen on an automated Qiacube processor (Qiagen AB,
Sweden) according to the manufacturer's instructions.3. Analysis
3.1. Liquid chromatography Tandem mass spectrometry (LC-MS/MS)
The sample processing of the liver biopsies was performed as
earlier described [11]. Samples were analyzed by using a Waters
Acquity™ I-class system (Waters, Milford, MA) equipped with a
Waters Acquity HSS T3 column (2.1100 mm, 1.8 mM) coupled to
a Waters Xevo TQ-S tandem quadrupole mass spectrometer (Wa-
ters, Manchester, UK) as earlier described [11,20,26].
3.2. Reverse transcription quantitative real-time polymerase chain
reaction (RT-qPCR)
The reverse transcription was performed using iScript (BioRad)
in all experiments/preparations and experimental accuracy wasTable 1
TaqMan assays, primer sequences.
Gene ID Primers Forward reverse Prob
GS GGAGAAAATCGAACCTGAAC AGA
TTCCCTGCCTGACATAGA
GR CTGACCAAGTCCCACATA CCG
TGAGGAGCTGTGTACTTC
GCLM GCTGGGATCTACTAACTA AAC
GGCATAAGAATATGAGGTTA
GCLC GGACAAACCCAAACCATC CCTC
CGGCGTTTCCTCATATTG
NFE2L2 CCAGAATTACAGTGTCTTAA CTG
TGAGGGATTTGGTGAATA
TGFB1 GCAGAGAGGCTATAGAGG TGC
CCAGAATTGAACCCGTTAA
HGF TGACCAAACTTCTACAAGTC CCTA
CTGTCCTTCTGCATAGGG
YWHAZ GAGACAACTTGACATTGTG CCTC
GAGGCAGACAAAAGTTG
ACTB TGCGACGTGGACATC AGG
CAGGGCCGTGATCTC
HPRT1 ACTGGAAAGAATGTCTTGA TTGC
CAAGGAAAGCAAGGTTTG
Porcine RT-qPCR primer/probe sets were designed in Beacon Designer 8.12 using GenBa
showing no sequence homologies of concern on other parts of the pig genome or exome
(6-FAM)/black hole quencher (BHQ1). Assay efﬁciency (E) was measured by serial dilutiimproved by running samples in duplicate [27]. All TaqMan assays
were designed in Beacon Designer 8 (Premier Biosoft, Palo Alto,
CA, USA) using porcine mRNA and DNA sequences retrieved from
GenBank. Probes were placed across exon splicing points to avoid
detection of genomic DNA. Where available, exon splicing points
were retrieved from GenBank, alternatively deducted by manual
alignment between mRNA and genomic sequences. Three candi-
date housekeeping genes were tested; hypoxanthine phosphor-
ibosyltransferase 1 (HPRT1), beta actin (ACTB) and tyrosine
3-monooxygenase/tryptophan 5-monooxygenase activation pro-
tein (YWHAZ). Assays were run using standard reaction conditions
(annealing/extension at 60 C; denaturation at 95 C; Mgþþ at
5 mM; Sso Advanced probe mastermix from BioRad) on a BioRad
CFX Connect platform. All assays were evaluated by measuring the
slope on a “standard curve” plot of a dilution series of a selected
sample. Primer sequences are listed in Table 1.3.3. Statistical analysis
The GSH and gene expression data were analyzed using re-
peated measures ANOVA by presenting differences over time
within the group or comparing groups over time (time by group)
(IBM SPSS Statistics 21 for Windows; SPSS Inc., Chicago, IL, USA).
All experiments were performed with a balanced design; thus type
I sum of squares was used. When deviation from the assumption
of sphericity was observed, adjustment of DF by Huynh-Feldt or
Greenhouse-Geisser was applied as appropriate. A simple contrast
was applied with the baseline measurement as reference. Fur-
thermore, post-hoc pairwise comparisons were run using Bon-
ferroni correction. For gene expression data, ΔCT values
(CTTargetCTReference) were calculated. As housekeeping (reference)
gene a construct variable of HPRT1, ACTB and YWHAZ was validated
to be stable across time-points and groups using repeated mea-
sures ANOVA. This constructed variable represented the CTReference
in calculating the ΔCT values. In case of non-Gaussian distributed
raw data, log-transformation was applied. Differences were con-
sidered statistically signiﬁcant at Po0.05.e Accession no E
ATTGTCTGCTACGACCTGGC NM_001244625 2.07
TTGACCTCTACTGTAGGCTG XM_003483635 1.98
TACCAAGCAAGGACACATAAGAA XM_001926378 2.11
CACCGTGTTGAACTCG XM_003482164 2.15
AGACTAGCACGGTTCCAAG XM_003133500 2.12
CCACTGTTCCTGTGACA NM_214015 2.14
CACCTCCTCCTGCTTCC XM_003130222 1.99
CTTCTCCTGCTTCAGC XM_001927228 2.04
ACCTCTACGCCAACACG XM_003357928 1.93
CAGTGTCAATTATATCTTCAACA NM_001032376 2.09
nk sequences as indicated. All primers and probes were subject to a BLAST search
. Sequences are listed 5′ to 3′. The probes were conjugated with ﬂuorescein amidite
on of cDNA prepared from total RNA extracted from pig liver.
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4.1. GSH
Raw data GSH values for the PHx- and control group are shown
in Fig. 2 with mean values in bold from baseline up until 12 h. No
signiﬁcant difference between the PHx- and control group was
observed at baseline (p¼0.2). There was a signiﬁcant effect of time
adjusted for group differences (ANOVA time p¼0.005). A simple
contrast against the baseline time-point showed signiﬁcant dif-
ferences at time-point 1 h, 3 h and 6 h (P¼0.006, P¼0.032,
P¼0.002 respectively, marked with asterisk in Fig. 2). There was
no signiﬁcant difference between the PHx- and the control group
over time (ANOVA interaction time group P¼0.247) and there
was no difference in grand mean between groups (P¼0.451). An
outlier can be noted in the PHx group showing high GSH values
from 6 h and through the experiment (Fig. 2). The RM-ANOVA was
rerun excluding this animal, but it did not change the conclusions
stated above.
4.2. RT-qPCR
4.2.1. Target genes related to GSH synthesis
Endogenous GSH levels are regulated by two pathways (Fig. 3),
i.e the GSH de novo synthesis and the GSH regeneration cycle [10].
4.2.2. Target genes related to the de novo synthesis of GSH and GSH
regeneration cycle
To examine the expression of genes involved in the GSH
synthesis, we measured the mRNA levels of target genes in the
PHx- and control group using qPCR on RNA isolated from liver
biopsies. Earlier reports suggest GSH synthase (GS) and glutamate
cysteine ligase subunits (GCLM and GCLC) to be the essential en-
zymes in the de novo GSH synthesis [19]. Further, transforming
growth factor-β1 (TGFβ1) and hepatocyte growth factor (HGF) are
described to have moderating effect on GSH synthesis, hence
TGFβ1 decreases GCLC activity and HGF stimulates both GCLM and
GCLC by increasing the enzymatic steps [19]. The transcription
factor nuclear factor erythroid 2 (NFE2L2) is described to be a
regulator in the GSH synthesis by speciﬁcally increasing GCLC geneFig. 2. Glutathione levels; presented as individual levels and as mean. Raw data of
GSH (glutathione) from start (baseline) until 12 h, individual presented for all 12
pigs. The estimated marginal means of GSH values in the PHx- and GSH group is
also presented in bold lines. N¼6 pigs in both groups. Baseline is mean GSH of
three biopsies in the PHx group and mean of two biopsies in the control group.
Asterisk indicates signiﬁcant deviation from baseline for all 12 observations as a
group.expression activity [19]. The GS gene expression was signiﬁcantly
different in the PHx group compared to the control group (ANOVA
interaction time group, P¼0.026). Hence, the gene expression of
GS in the PHx group was signiﬁcantly lower the ﬁrst nine hours
(Contrast vs baseline: 0.5 h P¼0.009, 1 h P¼0.012, 1.5 h P¼0.042,
5 h P¼0.049, 9 h P¼0.048), then the gene expression increased
and did not differ from the control group the last three hours
(Fig. 4A and B). Further, the enzyme subunits GCLC and GCLM
showed no signiﬁcant differences between the PHx- and control
group, P¼0.058 and P¼0.356 respectively (interaction time-
 group). Still, there was a group independent signiﬁcant change
over time in the gene expression within these two enzyme sub-
units (Po0.0005 for both), as well as within GS (Po0.0005).
The second pathway regulating the GSH level is reduction of
GSSG by glutathione reductase (GR) [10] (Fig. 3). The GR gene
expression (Figs. 4A and 4B) did not show any signiﬁcant differ-
ences between the PHx- and the control group (interaction time-
 group P¼0.481). A group independent signiﬁcant change in
gene expression over time was detected (P¼0.015). A simple
contrast against the baseline showed signiﬁcant differences at the
time-points 1.5 h, 3 h, 5 h, 7 h, with P¼0.045, P¼0.013, P¼0.023,
P¼0.006 respectively.
Gene expression of the three regulators in the GSH synthesis
(NFE2L2, TGFβ1, HGF in Fig. 5A and B) showed that the time-course
in all three regulators were signiﬁcantly different in the PHx group
compared to the control group (interaction time  group
P¼0.014, P¼0.029, P¼0.011 respectively). In more details, the
gene expression of NFE2L2 was signiﬁcantly lower the ﬁrst nine
hours in the PHx group (0.5 h P¼0.001, 1 h P¼0.003, 1.5 h
P¼0.014, 3 h P¼0.007, 7 h P¼0.001, 9 h P¼0.045 (Fig. 5A). Fur-
ther, the gene expression of TGFβ1 was also signiﬁcantly lower the
ﬁrst seven hours in the PHx group (0.5 h P¼0.033, 1 h P¼0.044,
3 h P¼0.011, 5 h P¼0.046, 7 h P¼0.009) (Fig. 5A). The gene ex-
pression of HGF was signiﬁcant lower in the PHx group compared
to the control group only at time-point 7 h (P¼0.000).5. Discussion
The current study presents a novel contribution in under-
standing in vivo GSH homeostasis after partial hepatectomy (PHx)
in a large animal experimental design utilizing the precision and
sensitivity of LC-MS/MS. In addition, we present transcriptional
variations in the genes regulating GSH synthesis as detected by RT-
qPCR speciﬁcally designed for the swine genome. The results show
that the liver has an extended capacity to maintain GSH metabo-
lism during major stress and parenchymal loss, even at the early
onset of such trauma.
Knowledge regarding in vivo GSH synthesis is limited [30],
consequently also in vivo reports on GSH synthesis after PHx are
lacking, especially in large animal models. Previous murine studies
have reported conﬂicting conclusions regarding GSH levels in the
liver remnant after PHx [14,16,28] however based on less sensitive
technologies than presented in the current report.
The GSH values in Fig. 2 presents the alteration of mean GSH
values in the PHx- and the control group during the immediate
12 h after a 60% PHx. There were no signiﬁcant differences in GSH
values between the two groups at any time during the experiment,
suggesting that even though the PHx group lost a major amount of
liver tissue and was exposed to complementary stress by surgery,
this did not alter the levels of hepatic GSH compared to the control
group. This is in agreement with earlier ﬁndings in murine studies
[28]. The ﬁrst six hours mean GSH decreased signiﬁcantly in both
groups. This reduction may be explained by the scavenging of GSH
due to the stress induced by anaesthesia/laparotomy [7], however
extended stress and liver volume loss did not alter the GSH levels
Fig. 3. Glutathione synthesis. GSH synthesis presented as GSH de novo synthesis and as a GSH regeneration cycle. Glutathione (GSH), glutathione disulﬁde (GSSG). Three
basic peptides in the GSH synthesis: Cysteine, glutamate and glycine. Essential enzymes in the GSH synthesis: glutamate cysteine ligase subunits (GCLM and GCLC) and
glutathione synthase (GS). Regulators in the GSH synthesis: transforming growth factor-β1 (TGFβ1), nuclear factor erythroid 2 (NFE2L2) and hepatocyte growth factor (HGF).
Stimulation and inhibition of the regulators on GCLM and GCLC are marked with add-mark and sub-mark respectively. In the GSH regeneration cycle GSH reductase (GR) and
GSH peroxidase (GPx) are the main enzymes.
Fig. 4. A and B: Gene expression (mRNA levels) by qPCR. A and B Relative gene expression (mRNA levels) by qPCR of the enzymes GCLC, GCLM and GS in GSH de novo
synthesis, including the enzyme GR in the GSH regeneration cycle. PHx group (A), control group (B). Values are generated by conversion of estimated marginal means from
the RM-ANOVA by fold change ¼2ΔΔCT.
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the GSH values in the PHx group tended to increase though not
signiﬁcantly, a tendency also seen in murine studies at 12 h after
PHx [16]. The overall interpretations of GSH levels after PHx in the
current study, may indicate that the early compensatory response
of GSH synthesis can contain the extra functional load triggered by
the surgical procedure per se even after organ reduction; this
concurs with earlier ﬁndings in rat liver [6,12]. As our data is based
on a 60% PHx, further studies with more radical PHx may reveal
the limits of this proposed compensatory mechanism; thus our
data cannot be directly extrapolated to more extensive PHx or
small-for-size models. However, the extent of resection modelFig. 5. A and B: Gene expression (mRNA levels) by qPCR. A and B Relative gene expressio
novo synthesis in the PHx group (A) and control group (B). Values are generated by convutilized in this model is clinically relevant because the major part
of liver resections for malignancy today are 60% or less when
performing right- or left sided hemi-hepatectomy.
Due to the results of sustained GSH levels, we then hypothe-
sized that the homeostasis of GSH was maintained in the PHx
group compared to the control group due to increased gene ex-
pression of key genes in the liver remnant.
The gene expression involved in the GSH de novo synthesis and
the GSH regeneration cycle was analyzed the ﬁrst 12 h after PHx
(Figs. 4 and 5). Contradictory to our hypothesis stated above, the
initial hours after PHx showed signiﬁcantly reduced mRNA ex-
pression in the PHx group compared to the control group the ﬁrstn (mRNA levels) by qPCR of three regulators (NFE2L2, TGFβ1 and HGF) in the GSH de
ersion of estimated marginal means from the RM-ANOVA by fold change¼2ΔΔCT.
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GSH level was maintained in the PHx group (Fig. 2). This ob-
servation may be counterintuitive. A possible explanation can be
that the immediate GSH production takes priority over de novo
production of proteins as part of an emergency response state
following PHx. Thus the GSH production capacity seems to exceed
the demands imposed by a 60% PHx, but at the cost of reducing
other processes like de novo synthesis of key enzymes. This may
be possible because the liver remnant probably contains enough
mature and pro-enzymes related to GSH synthesis to buffer the
early stress. However, the limits for this surplus capacity may be
reached with more radical resections.
Earlier murine studies with longer time frames have shown
GSH levels in the PHx group exceeding the control group by 2-fold
the ﬁrst 24 h [14,16] and 48 h [28], a 2-fold difference persisting
for 72 h [16] and not reverting to normal GSH values until ﬁve days
after PHx [28]. This trend could not be demonstrated in our data,
which may be explained to the shorter time frame in the present
experiment. Unfortunately, a ﬁve day experiment post-PHx in pigs
is not easily performed, but future experimental setups may proﬁt
from extending the time frame in order to investigate if a parallel
increase of GSH levels can be seen after PHx in swine. As for all
large animal experimental models with limited total number of
animals included, the results will mainly detect large differences
and/or trends due to the statistic power in the study. Yet, this latter
must not reduce the emphasis of utilizing in vivo large animal
models comparable with human physiology and anatomy, like the
pig, in order to understand in vivo hepatic GSH synthesis.
The method of quantifying GSH proved to be sensitive, by de-
tecting signiﬁcant alterations of GSH values over time within the
groups, corresponding to our earlier method evaluation [11]. The
observed outlier animal with increased GSH levels in Fig. 2 also
demonstrates the sensitivity of the method. This pig was exposed
to additional stress by gastroenteritis the week before the ex-
periment and furthermore developed larynx spasm during the
initial phase of anaesthesia, complicating the experiment.
The results in this study represent the ﬁrst attempt to in-
vestigate alterations in GSH levels after PHx in an in vivo swine
model using LC-MS/MS. By presenting these results with a sensi-
tive methodological platform, the current report may contribute to
future research on the impact of PHx on post-operative oxidative
state. Moreover, with this knowledge of GSH levels in the liver
remnant, several clinical concerns in post-PHx progress may be
addressed, including GSH inﬂuence on liver regeneration in dis-
eased liver requiring partial hepatectomy, as well as GSH protec-
tion of hepatocytes in the liver remnant when required adminis-
tration of various medication or analgesia with liver elimination.
In conclusion, the levels of GSH were maintained in the liver
remnant compared to the control group during the ﬁrst 12 h after
partial hepatectomy in anesthetized pigs. The gene expression of
the key genes in the GSH synthesis were decreased in the liver
remnant during the greater part of the experiment, thereby not
explaining this observation. Consequently, the maintenance of
GSH homeostasis in the early phase rely on other factors than de
novo production of proteins, such as an extended capacity of en-
zymes at hand, and possible readily mobilized pro-enzymes.Grants
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